Your browser doesn't support javascript.
loading
BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
Ries, Christina; Beer, Martin; Hoffmann, Bernd.
Afiliação
  • Ries C; Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Südufer 10, 17943 Greifswald - Insel Riems, Germany.
  • Beer M; Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Südufer 10, 17943 Greifswald - Insel Riems, Germany.
  • Hoffmann B; Friedrich-Loeffler-Institut, Institute of Diagnostic Virology, Südufer 10, 17943 Greifswald - Insel Riems, Germany. Electronic address: bernd.hoffmann@fli.de.
Vaccine ; 37(20): 2656-2660, 2019 05 06.
Article em En | MEDLINE | ID: mdl-30979569
ABSTRACT
The Bluetongue virus serotype -8 (BTV-8) epizootic in Germany (2006-2008) was successfully eradicated, essentially by the massive application of commercially available inactivated BTV-8 vaccines. While a six-year antibody longevity of BTV antibodies post BTV-8 vaccination in cattle has been described previously, our study investigated the BTV-8-vaccine antibodies in cattle for up to eight years. In total, 157 bovine serum samples were analysed for the presence of group-specific BTV antibodies in both a commercial cELISA, and a BTV-8- specific serum neutralization test. A robust number of cattle were seropositive for group- and serotype-specific neutralising antibodies for five or more years. In selected animals, born and vaccinated in 2009 or later, the presence of BTV antibodies for up to eight years post BTV-8 vaccination could be confirmed. Our data also show, that booster vaccination prolonged the antibody longevity of vaccine-induced antibodies and the number of serologically positive cattle.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Bluetongue / Vírus Bluetongue / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Bluetongue / Vírus Bluetongue / Anticorpos Antivirais Idioma: En Ano de publicação: 2019 Tipo de documento: Article